Skip to main content

March/April 2012, Vol 5, No 2

Original Research
Benefits of Novel Oral Anticoagulant Agents for Thromboprophylaxis after Total Hip or Knee Arthroplasty
Richard J. Friedman, MD, FRCSC
Stakeholder Perspective
A Paradigm Shift in Anticoagulation?
by Atheer A. Kaddis, PharmD
Read More
Perspectives
A New Beginning
David B. Nash, MD, MBA
Read More
Practice Management
Trends in Biologic Therapies for Rheumatoid Arthritis: Results from a Survey of Payers and Providers
Rhonda Greenapple, MSPH
Stakeholder Perspective
Biologic Therapies for Rheumatoid Arthritis: It's All about Value
by Albert Tzeel, MD, MHSA, CPE, FAAPL
Read More
Practice Management
Impact of the Removal of the Monthly Liver Function Test Requirement for Ambrisentan
Louise A. Durst, RN, John Carlsen, MHA, Megan Kuchinski, MPH, Lauren Harner, JD, Daniel Neves, BA, Stephanie J. Harris, RN, BSN, Glenna L. Traiger, RN, MSN, CNS-BC
Stakeholder Perspective
The Challenges of Pulmonary Arterial Hypertension Management: Potential Benefits of Removing Monthly Testing
by James T. Kenney, RPh, MBA
Read More

Results 1 - 4 of 4